Clinical Trial Update: Induction IBI110 and Sintilimab with Chemotherapy in LA HNSCC [Phase 1, Phase 2]

View source ↗

Summary

This is a Phase 1/2 clinical trial sponsored by Fudan University evaluating induction with IBI110 and Sintilimab in combination with chemotherapy for locally ad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• IBI110 (IBI110)
• Sintilimab (sintilimab)

Snippet

Sponsor: Fudan University | Conditions: Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma | Phase 1, Phase 2 | Status: RECRUITING